ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance

التفاصيل البيبلوغرافية
العنوان: ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance
المؤلفون: Bruce J. Auerbach, Roger S. Newton, K.A. Kieft, M E Pape, Reynold Homan, Charles L. Bisgaier, Brian R. Krause
المصدر: Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 14:598-604
بيانات النشر: Ovid Technologies (Wolters Kluwer Health), 1994.
سنة النشر: 1994
مصطلحات موضوعية: Male, medicine.medical_specialty, Very low-density lipoprotein, Apolipoprotein B, Hypercholesterolemia, Sterol O-acyltransferase, Biology, chemistry.chemical_compound, Cytochrome P-450 Enzyme System, Internal medicine, medicine, Animals, Anilides, RNA, Messenger, Cholesterol, Reverse cholesterol transport, Cholesterol, LDL, Dietary Fats, Endocrinology, Receptors, LDL, chemistry, Steroid Hydroxylases, LDL receptor, Cholesteryl ester, biology.protein, Hydroxymethylglutaryl CoA Reductases, lipids (amino acids, peptides, and proteins), Aryl Hydrocarbon Hydroxylases, Rabbits, Cardiology and Cardiovascular Medicine, Sterol O-Acyltransferase, Lipoprotein
الوصف: Rabbits fed low-fat, cholesterol-free diets containing casein as the sole protein source develop endogenous hypercholesterolemia (EH). To test the hypothesis that lipoprotein cholesteryl esters in EH rabbits are acyl coenzyme A:cholesterol acyltransferase (ACAT) derived, we treated EH rabbits with CI-976, a potent and selective ACAT inhibitor. In addition, since cholesterol and bile acid synthesis as well as low-density lipoprotein (LDL) receptor activity are reduced in EH rabbits, we determined whether changes in gene expression for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, 7 alpha-hydroxylase, and the LDL receptor might be associated with the efficacy due to ACAT inhibition. Compared with EH controls, CI-976-treated rabbits (50 mg/kg per day for 5 weeks) had decreased plasma total cholesterol (-43%), very-low-density lipoprotein (VLDL) cholesterol (-62%), LDL cholesterol (-43%), plasma apolipoprotein B (-23%), liver cholesteryl esters (-39%), LDL size, VLDL and LDL cholesteryl ester content (percent of total lipids), cholesteryl oleate/cholesteryl linoleate ratios in VLDL and LDL (25% to 30%), and ex vivo liver ACAT activity. The triglyceride/cholesteryl ester ratio increased twofold to fourfold in these apolipoprotein B-containing lipoproteins. Endogenous cholesterol absorption appeared to be unaffected by drug treatment. CI-976 failed to alter specific hepatic mRNAs involved in cholesterol metabolism, but comparisons among dietary control groups revealed a marked reduction in 7 alpha-hydroxylase mRNA, no change in LDL receptor mRNA, and an increase in HMG-CoA reductase mRNA in EH rabbits compared with normal chow-fed controls.(ABSTRACT TRUNCATED AT 250 WORDS)
تدمد: 1049-8834
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da883b8d3cabc32bf49a9e8ac0b6adb
https://doi.org/10.1161/01.atv.14.4.598
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....6da883b8d3cabc32bf49a9e8ac0b6adb
قاعدة البيانات: OpenAIRE